Our Vision

We expose complex diseases with high precision at an early stage to improve and save lives.

Our Mission

We develop solutions to discover complex disease patterns by enabling comprehensive and automated interpretation of single-cell data for scientists and healthcare professionals.

About Scailyte AG

Extracting knowledge from single-cell data to save millions of lives

A new and emerging type of analytical devices produce rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection, but it requires sophisticated and innovative computational approaches in order to extract the relevant information.

We address this problem by developing artificial intelligence (AI) software for single-cell data analysis. The underlying algorithms allow us to associate patterns in single-cell data with disease status, similar to how state-of-the-art methods for object recognition associate pixel patterns with objects. We provide a software solution (ScaiVision), wrapping our AI technology for R&D customers from academia, pharmaceutical and clinics.

Additionally, through our ScaiBioMarker Discovery service, by partnering with pharmaceutical & biotechnology companies we provide our single-cell technology and expertise for novel biomarker discovery, which will yield ultra-sensitive biomarkers for early and precise detection of a wide range of complex diseases.

Executive Management Team


Dr. Peter Nestorov Founder & CEO

Peter studied Biochemistry in Tübingen and obtained a PhD in Genetics in Basel. He has experience in biomedical research and is an expert in genomics applications and technologies. Following his PhD, Peter took a sales role and developed a network of customers and industry partners from the Single-Cell Analysis market.

Peter is guiding Scailyte towards its mission by building relationships with partners and customers and by inspiring the team to deliver a solution that will save millions of lives.


Anna Dimitrova, ACCA Director of Finance & Operations

Anna has degrees in Economics and Finance from Sofia University and a professional ACCA qualification. She has more than 8 years experience as a business consultant and auditor in Big 4 companies (KPMG and PwC). In the last 6 years, Anna has served as an executive and a trusted business advisor in the NGO and the B2B Services sector.

Anna is managing Scailyte’s finances and plays a key role in defining and implementing our business and funding strategies.

Stefan Almestrand

Stefan Almestrand Director of Sales & Marketing

Stefan studied chemical engineering and biotechnology at Mälardalen University and at the Royal institute of technology in Stockholm, Sweden. He spent 4 years in genomics and proteomics research focusing on hematological malignancies from Karolinska institutet. Following his research career, Stefan went to industry and has been working in EMEA and globally the last 10 years with sales, partnering, market and business development towards clinical diagnostics, precision medicine and companion diagnostics.

Stefan is responsible for all commercial aspects at Scailyte.


Prof. Dr. Manfred Claassen Founder & Chairman of Scientific Advisory Board

Manfred did parallel studies in Biochemistry and Computer Science at the University of Tübingen, followed by a PhD in machine learning at ETH Zürich. For his postdoctoral studies, Manfred moved to the Artificial Intelligence Laboratory in Stanford. In 2013 he became a group leader and Assistant Professor at ETH Zürich. His research is focused on computational single-cell biology in the context of cancer, infectious diseases and immune disorders.

Manfred is responsible for the scientific and clinical collaborations at Scailyte, which are fueling our technological and IP portfolios.


Dr. Dennis Göhlsdorf Founder & Lead Software Eng.

Dennis has degrees in Biochemistry and Computer Science from the university of Tübingen and did his PhD in Neuroinformatics at ETH Zurich. His work focused on solving motion planning tasks using algorithms from machine learning and artificial intelligence. After that, he worked for Google as a software engineer and has more than 20 years of experience in software development.

Dennis is leading the product development and implementation of our artificial intelligence technology.


Dr. Daniel Sonnleithner Founder & Director of Data Analytics

Daniel studied Mechanical Engineering, and Mechatronics in Karlsruhe. During his PhD in Neuroinformatics at ETH Zurich, he developed complex software systems. Afterwards, he worked for AWK, a Swiss IT consulting company, where he gained extensive experience in managing projects.

At Scailyte, Daniel is ensuring that our core product is designed according to customer needs, meets highest quality standards, and receives great support. Furthermore, Daniel is responsible for Scailyte's IT infrastructure.


masschallenge winner


MassChallenge is a global non-profit startup accelerato​ r and competition with a focus on high-impact, early-stage entrepreneurs.To date, MassChallenge has accelerated 1,211 startups, which together have raised $1.8 billion in funding, generated over $700 million in revenue and created over 60,000 direct and indirect jobs across the world.

Each year, MassChallenge admits over 300 finalists to its three- to four-month accelerator program across its five locations: Boston, Israel, Mexico, Switzerland, and the UK. These accelerators provide startups with free office space, mentorship and more. At the end of the program, the most promising startups are awarded equity-free cash prizes.

ETH Zurich biomedical

ETH Zürich

ETH Zürich is a university focusing on science, technology, engineering and mathematics in the city of Zürich, Switzerland. In the 2019 edition of the QS World University Rankings ETH Zürich is ranked 7th in the world.

Scailyte AG officially received the ETH Spin-off label by ETH Zürich. We will receive support in various activities for the initial years after incorporation.

Venture 2017


>>venture>> is an initiative of the ETH Zurich, McKinsey & Company Switzerland, Knecht Holding, the innovation promotion agency CTI, and École Polytechnique Fédérale de Lausanne (EPFL). The leading Swiss-wide startup competition supports young entrepreneurs in founding a company.

Scailyte participated in the 2017 »venture» competition and received coaching and valuable feedback from experts and investors. Our project was ranked among the Top25 business ideas from more than 100 projects in this track.

Eidgenossenschaft 2017


Innosuisse is the Swiss Confederation’s innovation promotion agency. It provides consultancy, networking services and financial resources to help turn scientific research into economic results.

Scailyte is part of the Inosuisse coaching program. We have passed the Coaching Acceptance in November 2017 and we are now working intensively with our Inosuisse coach to fine-tune our business plan and implement the go-to-market strategy.

Venturekick 2017

Venture Kick

Venture Kick aims for an early detection and promotion of promising business ideas at Swiss universities and schools of higher education. Scailyte qualified for coaching and financial support after passing the first selection round in 2017.